CANARY Technology

A novel biosensor with unprecedented performance

CANARY® (Cellular Analysis and Notification of Antigen Risks and Yields) is a cell-based biosensor technology that delivers extremely rapid detection of pathogens at previously unseen levels of sensitivity and specificity.

Developed by the scientists at MIT-Lincoln Laboratories, CANARY® incorporates pathogen-specific antibodies expressed on the biosensor surface which, in the presence of a pathogen (virus, bacteria or toxin), trigger an intracellular calcium release that in turn activates bioluminescent proteins whose light output can be measured and analyzed.

To learn more, watch "Building the Biosensor":

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player